Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Cardiovascular Stroke

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrett, TD; Fischbach, PS; Lucchesi, BR; Reed, NJ1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Cardiovascular Stroke

ArticleYear
SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:5

    Topics: Adenosine Triphosphate; Animals; Benzamides; Female; Heart; In Vitro Techniques; Ion Channel Gating; Ischemic Preconditioning, Myocardial; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Pinacidil; Piperazines; Potassium Channels; Rabbits; Receptors, Opioid, delta; Vasodilator Agents; Ventricular Fibrillation

2003